177 related articles for article (PubMed ID: 34633095)
1. AT-rich interaction domain 5A regulates the transcription of interleukin-6 gene in prostate cancer cells.
Ikeuchi W; Wakita Y; Zhang G; Li C; Itakura K; Yamakawa T
Prostate; 2022 Jan; 82(1):97-106. PubMed ID: 34633095
[TBL] [Abstract][Full Text] [Related]
2. TLR4-induced NF-κB and MAPK signaling regulate the IL-6 mRNA stabilizing protein Arid5a.
Nyati KK; Masuda K; Zaman MM; Dubey PK; Millrine D; Chalise JP; Higa M; Li S; Standley DM; Saito K; Hanieh H; Kishimoto T
Nucleic Acids Res; 2017 Mar; 45(5):2687-2703. PubMed ID: 28168301
[TBL] [Abstract][Full Text] [Related]
3. Arid5a/IL-6/PAI-1 Signaling Is Involved in the Pathogenesis of Lipopolysaccharide-Induced Kidney Injury.
Tanaka K; Harada H; Kamuro H; Sakai H; Yamamoto A; Tomimatsu M; Ikeda A; Chosokabe R; Tanaka S; Okada Y; Fujio Y; Obana M
Biol Pharm Bull; 2023; 46(12):1753-1760. PubMed ID: 38044094
[TBL] [Abstract][Full Text] [Related]
4. Arid5a stabilizes OX40 mRNA in murine CD4
Hanieh H; Masuda K; Metwally H; Chalise JP; Mohamed M; Nyati KK; Standley DM; Li S; Higa M; Zaman MM; Kishimoto T
Eur J Immunol; 2018 Apr; 48(4):593-604. PubMed ID: 29244194
[TBL] [Abstract][Full Text] [Related]
5. Constitutive activation of nuclear factor kappaB p50/p65 and Fra-1 and JunD is essential for deregulated interleukin 6 expression in prostate cancer.
Zerbini LF; Wang Y; Cho JY; Libermann TA
Cancer Res; 2003 May; 63(9):2206-15. PubMed ID: 12727841
[TBL] [Abstract][Full Text] [Related]
6. AT-rich interactive domain 5B regulates androgen receptor transcription in human prostate cancer cells.
Yamakawa T; Waer C; Itakura K
Prostate; 2018 Dec; 78(16):1238-1247. PubMed ID: 30027545
[TBL] [Abstract][Full Text] [Related]
7. Arid5a-deficient mice are highly resistant to bleomycin-induced lung injury.
Dubey PK; Masuda K; Nyati KK; -Uz Zaman MM; Chalise JP; Millrine D; Kai W; Ripley B; Kishimoto T
Int Immunol; 2017 Feb; 29(2):79-85. PubMed ID: 28379390
[TBL] [Abstract][Full Text] [Related]
8. IL-17 integrates multiple self-reinforcing, feed-forward mechanisms through the RNA binding protein Arid5a.
Amatya N; Childs EE; Cruz JA; Aggor FEY; Garg AV; Berman AJ; Gudjonsson JE; Atasoy U; Gaffen SL
Sci Signal; 2018 Oct; 11(551):. PubMed ID: 30301788
[TBL] [Abstract][Full Text] [Related]
9. Arid5a controls IL-6 mRNA stability, which contributes to elevation of IL-6 level in vivo.
Masuda K; Ripley B; Nishimura R; Mino T; Takeuchi O; Shioi G; Kiyonari H; Kishimoto T
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9409-14. PubMed ID: 23676272
[TBL] [Abstract][Full Text] [Related]
10. Arid5a exacerbates IFN-γ-mediated septic shock by stabilizing T-bet mRNA.
Zaman MM; Masuda K; Nyati KK; Dubey PK; Ripley B; Wang K; Chalise JP; Higa M; Hanieh H; Kishimoto T
Proc Natl Acad Sci U S A; 2016 Oct; 113(41):11543-11548. PubMed ID: 27671645
[TBL] [Abstract][Full Text] [Related]
11. Recent Advances in the Role of Arid5a in Immune Diseases and Cancer.
Nyati KK; Kishimoto T
Front Immunol; 2021; 12():827611. PubMed ID: 35126382
[TBL] [Abstract][Full Text] [Related]
12. Arid5a regulates naive CD4+ T cell fate through selective stabilization of Stat3 mRNA.
Masuda K; Ripley B; Nyati KK; Dubey PK; Zaman MM; Hanieh H; Higa M; Yamashita K; Standley DM; Mashima T; Katahira M; Okamoto T; Matsuura Y; Takeuchi O; Kishimoto T
J Exp Med; 2016 Apr; 213(4):605-19. PubMed ID: 27022145
[TBL] [Abstract][Full Text] [Related]
13. Arid5a Mediates an IL-17-Dependent Pathway That Drives Autoimmunity but Not Antifungal Host Defense.
Taylor TC; Li Y; Li DD; Majumder S; McGeachy MJ; Biswas PS; Gingras S; Gaffen SL
J Immunol; 2022 Sep; 209(6):1138-1145. PubMed ID: 35940634
[TBL] [Abstract][Full Text] [Related]
14. Arid5a Regulation and the Roles of Arid5a in the Inflammatory Response and Disease.
Nyati KK; Agarwal RG; Sharma P; Kishimoto T
Front Immunol; 2019; 10():2790. PubMed ID: 31867000
[TBL] [Abstract][Full Text] [Related]
15. The novel long noncoding RNA AU021063, induced by IL-6/Arid5a signaling, exacerbates breast cancer invasion and metastasis by stabilizing Trib3 and activating the Mek/Erk pathway.
Nyati KK; Hashimoto S; Singh SK; Tekguc M; Metwally H; Liu YC; Okuzaki D; Gemechu Y; Kang S; Kishimoto T
Cancer Lett; 2021 Nov; 520():295-306. PubMed ID: 34389433
[TBL] [Abstract][Full Text] [Related]
16. Arid5a, an RNA-Binding Protein in Immune Regulation: RNA Stability, Inflammation, and Autoimmunity.
Nyati KK; Zaman MM; Sharma P; Kishimoto T
Trends Immunol; 2020 Mar; 41(3):255-268. PubMed ID: 32035762
[TBL] [Abstract][Full Text] [Related]
17. Feedback regulation of Arid5a and Ppar-γ2 maintains adipose tissue homeostasis.
Chalise JP; Hashimoto S; Parajuli G; Kang S; Singh SK; Gemechu Y; Metwally H; Nyati KK; Dubey PK; Zaman MM; Nagahama Y; Hamza H; Masuda K; Kishimoto T
Proc Natl Acad Sci U S A; 2019 Jul; 116(30):15128-15133. PubMed ID: 31289228
[TBL] [Abstract][Full Text] [Related]
18. Regulation of inflammatory responses by dynamic subcellular localization of RNA-binding protein Arid5a.
Higa M; Oka M; Fujihara Y; Masuda K; Yoneda Y; Kishimoto T
Proc Natl Acad Sci U S A; 2018 Feb; 115(6):E1214-E1220. PubMed ID: 29358370
[TBL] [Abstract][Full Text] [Related]
19. A Potential Therapeutic Target RNA-binding Protein, Arid5a for the Treatment of Inflammatory Disease Associated with Aberrant Cytokine Expression.
Masuda K; Kishimoto T
Curr Pharm Des; 2018; 24(16):1766-1771. PubMed ID: 29701145
[TBL] [Abstract][Full Text] [Related]
20.
von Ehr J; Korn SM; Weiß L; Schlundt A
Biomol NMR Assign; 2023 Jun; 17(1):121-127. PubMed ID: 37129704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
